Clinical Trial Update: A Phase II Study of H56:IC31 in Healthy Adolescents [Phase 2]

View source ↗

Summary

A Phase II study of the TB vaccine H56:IC31 in healthy adolescents has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• H56:IC31

Snippet

Sponsor: Aeras | Conditions: Tuberculosis Infection | Phase 2 | Status: WITHDRAWN